Skip to content
DataLookout
Menu

NCT07919860

Observation Study on the Efficacy and Safety of Hepatic Artery Embolization Combined With Radiofrequency Ablation for Hepatic Hemangioma: The Impact of Different Treatment Intervals

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Tumour volume reduction rate
Timeframe: 6 month and 12 month post RFA

Secondary (1)

Peri-procedural complication incidence

Arms and interventions

Short-interval group

RFA is performed at 10-14 days after TAE

Long-interval group

RFA is performed at 2-3 months after TAE

Procedures: transcatheter arterial embolization (TAE), radiofrequency ablation (RFA)